Skip to main content

Find Clinical Trials

Home
Conditions
Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men

Clinical trial condition

Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men

Explore clinical trials studying Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men. Study availability and eligibility vary by location and protocol.

14 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men trial results

Completed

A Study to Learn How Safe Elinzanetant is, How it Affects the Body, and How it Moves Into, Through and Out of the Body After Single and Multiple Doses in Japanese Healthy Female Adults

NCT04981431

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine Gland Neoplasms, Endocrine System Diseases, +8 more
Locations: SOUSEIKAI Fukuoka Mirai Hospital Fukuoka, Japan

View Trial Details

Completed

A Study to Learn How Different Levels of Decreased Liver Function Influence Blood Levels of Elinzanetant Compared to Normal Liver Function in Male and Female Participants

NCT04903821

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine Gland Neoplasms, Endocrine System Diseases, +8 more
Locations: APEX GmbH München, Bavaria, Germany

CRS Clinical-Research-Services Kiel GmbH Kiel, Schleswig-Holstein, Germany

View Trial Details

Completed

A Study to Learn How a Proton Pump Inhibitor Affects the Way Elinzanetant (BAY 3427080) Moves Into, Through and Out of the Body, and How Much of it Gets Absorbed by the Body When Taken as a Single and Small Radioactive Dose in Healthy Adults

NCT05061563

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine Gland Neoplasms, Endocrine System Diseases, +11 more
Locations: PRAHealthSciences Groningen, Netherlands

View Trial Details

Completed

A Study to Learn What Happens to Elinzanetant in the Body When Taken With or Without Carbamazepine, and How Safe it is in Healthy Men and Women Aged 18 to 60 Years.

NCT05028608

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine Gland Neoplasms, Endocrine System Diseases, +8 more
Locations: CRS Clinical-Research-Services Mannheim GmbH Mannheim, Baden-Wurttemberg, Germany

View Trial Details